Boston, MA
Summary
This Boston-based therapeutics company utilizes advanced artificial intelligence, physics-based tools, and automation to discover novel small molecules aimed at difficult targets. The company is currently advancing its lead asset through IND-enabling studies and is focused on developing treatments for inflammatory and immune diseases, including multiple autoimmune conditions.
We offer API access to our data.
8 of 8 checks passed
Label
Value
Active Dates
5.5 years — Since Jul 2019
Web Hosting
Platform
E-Mail Provider
Mimecast
NAICS Code
325412
SIC 4 Digit Code
2834
SIC 2 Digit Code
28
Industry
1. Pharmaceuticals and Biotechnology
2. Pharmaceutical Preparation Manufacturing
Vendor
Source
Microsoft
TXT Record
Apple
TXT Record
Atlassian
TXT Record
TXT Record
TeamViewer
TXT Record
Mimecast
TXT Record
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2024 |
|
|
|
|
|
|
|
|
|
|
|
|